Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance
- PMID: 35847117
- PMCID: PMC9284026
- DOI: 10.3389/fmicb.2022.887251
Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance
Abstract
Antimicrobial resistance in clinically important microbes has emerged as an unmet challenge in global health. Extensively drug-resistant bacterial pathogens have cropped up lately defying the action of even the last resort of antibiotics. This has led to a huge burden in the health sectors and increased morbidity and mortality rate across the world. The dwindling antibiotic discovery pipeline and rampant usage of antibiotics has set the alarming bells necessitating immediate actions to combat this looming threat. Various alternatives to discovery of new antibiotics are gaining attention such as reversing the antibiotic resistance and hence reviving the arsenal of antibiotics in hand. Antibiotic resistance reversal is mainly targeted against the antibiotic resistance mechanisms, which potentiates the effective action of the antibiotic. Such compounds are referred to as resistance breakers or antibiotic adjuvants/potentiators that work in conjunction with antibiotics. Many studies have been conducted for the identification of compounds, which decrease the permeability barrier, expression of efflux pumps and the resistance encoding enzymes. Compounds targeting the stability, inheritance and dissemination of the mobile genetic elements linked with the resistance genes are also potential candidates to curb antibiotic resistance. In pursuit of such compounds various natural sources and synthetic compounds have been harnessed. The activities of a considerable number of compounds seem promising and are currently at various phases of clinical trials. This review recapitulates all the studies pertaining to the use of antibiotic potentiators for the reversal of antibiotic resistance and what the future beholds for their usage in clinical settings.
Keywords: antibiotic potentiators; antimicrobial resistance (AMR); mobile genetic elements (MGEs); multidrug resistance; pathogens; reversal of antibiotic resistance.
Copyright © 2022 Chawla, Verma, Gupta and Das.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Antibiotic Potentiation as a Promising Strategy to Combat Macrolide Resistance in Bacterial Pathogens.Antibiotics (Basel). 2023 Dec 11;12(12):1715. doi: 10.3390/antibiotics12121715. Antibiotics (Basel). 2023. PMID: 38136749 Free PMC article. Review.
-
β-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward.Front Microbiol. 2023 Mar 10;13:1092556. doi: 10.3389/fmicb.2022.1092556. eCollection 2022. Front Microbiol. 2023. PMID: 36970185 Free PMC article. Review.
-
Inhibiting Bacterial Drug Efflux Pumps via Phyto-Therapeutics to Combat Threatening Antimicrobial Resistance.Front Microbiol. 2018 Dec 10;9:2990. doi: 10.3389/fmicb.2018.02990. eCollection 2018. Front Microbiol. 2018. PMID: 30619113 Free PMC article. Review.
-
The alarming antimicrobial resistance in ESKAPEE pathogens: Can essential oils come to the rescue?Fitoterapia. 2020 Jan;140:104433. doi: 10.1016/j.fitote.2019.104433. Epub 2019 Nov 21. Fitoterapia. 2020. PMID: 31760066 Review.
-
Advances in the Discovery of Efflux Pump Inhibitors as Novel Potentiators to Control Antimicrobial-Resistant Pathogens.Antibiotics (Basel). 2023 Sep 7;12(9):1417. doi: 10.3390/antibiotics12091417. Antibiotics (Basel). 2023. PMID: 37760714 Free PMC article. Review.
Cited by
-
Recent Advances in the Development of Antibiotics-Coated Gold Nanoparticles to Combat Antimicrobial Resistance.Antibiotics (Basel). 2024 Jan 26;13(2):124. doi: 10.3390/antibiotics13020124. Antibiotics (Basel). 2024. PMID: 38391510 Free PMC article. Review.
-
Co-Delivery of Naringin and Ciprofloxacin by Oleic Acid Lipid Core Encapsulated in Carboxymethyl Chitosan/Alginate Nanoparticle Composite for Enhanced Antimicrobial Activity.ACS Omega. 2024 Feb 2;9(6):6845-6860. doi: 10.1021/acsomega.3c08200. eCollection 2024 Feb 13. ACS Omega. 2024. PMID: 38371782 Free PMC article.
-
Punicalagin, a pomegranate polyphenol sensitizes the activity of antibiotics against three MDR pathogens of the Enterobacteriaceae.BMC Complement Med Ther. 2024 Feb 16;24(1):93. doi: 10.1186/s12906-024-04376-7. BMC Complement Med Ther. 2024. PMID: 38365729 Free PMC article.
-
Fitness trade-offs of multidrug efflux pumps in Escherichia coli K-12 in acid or base, and with aromatic phytochemicals.Appl Environ Microbiol. 2024 Feb 21;90(2):e0209623. doi: 10.1128/aem.02096-23. Epub 2024 Jan 30. Appl Environ Microbiol. 2024. PMID: 38289137 Free PMC article.
-
Novel Hydroxamic Acids Containing Aryl-Substituted 1,2,4- or 1,3,4-Oxadiazole Backbones and an Investigation of Their Antibiotic Potentiation Activity.Int J Mol Sci. 2023 Dec 20;25(1):96. doi: 10.3390/ijms25010096. Int J Mol Sci. 2023. PMID: 38203266 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
